A 2015 global update on folic acid-preventable spina bifida and anencephaly

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 106, Issue 7, 2016, Pages 520-529

  Arth, Annelise ^a   Kancherla, Vijaya ^a   Pachón, Helena ^a,b   Zimmerman, Sarah ^b   Johnson, Quentin ^b   Oakley, Godfrey P ^a  

^a EMORY UNIVERSITY   (United States)

^b Mailstop: 1599 001 1BX (SPH: Global Health)   (United States)

Author keywords

anencephaly; epidemiology; flour fortification; folic acid; prevention; spina bifida

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; ARTICLE; DIETARY INTAKE; FLOUR; FORTIFIED FOOD; GEOGRAPHIC DISTRIBUTION; HUMAN; LAW; MAIZE; NEURAL TUBE DEFECT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SPINAL DYSRAPHISM; WHEAT; ANENCEPHALY; FEMALE; MALE;

ANENCEPHALY; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; MALE; SPINAL DYSRAPHISM;

EID: 84978835944     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23529     Document Type: Article

References (37)

1. Ahrens K, Yazdy MM, Mitchell AA, Werler MM. 2011. Folic acid intake and spina bifida in the era of dietary folic acid fortification. Epidemiology 22:731–737.
2. Bell KN, Oakley GP Jr. 2006. Tracking the prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol 76:654–657.
3. Bell KN, Oakley GP Jr. 2009. Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol 85:102–107.
4. Berry RJ, Li Z, Erickson JD, Li S, et al. 1999. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485–1490.
5. Berry RJ, Carter HK, Yang Q. 2007. Cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 86:265–267; author reply 267–269.
6. Bhutta ZA, Das JK, Bahl R, et al. 2014. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost? Lancet 384:347–370.
7. Botto LD, Moore CA, Khoury MJ, Erickson JD. 1999. Neural-tube defects. N Engl J Med 341:1509–1519.
8. Castillo-Lancellotti C, Tur JA, Uauy R. 2013. Impact of folic acid fortification of flour on neural tube defects: a systematic review. Public Health Nutr 16:901–911.
9. Christianson A, Modell B. 2006. March of Dimes global report on birth defects: the hidden toll of dying and disabled children. White Plains: March of Dimes.
10. Cortes F, Mellado C, Pardo RA, et al. 2012. Wheat flour fortification with folic acid: changes in neural tube defects rates in Chile. Am J Med Genet A 158:1885–1890.
11. Crider KS, Devine O, Hao L, et al. 2014. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ (Clinical research ed) 349:g4554.
12. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832–1835.
13. Daly LE, Kirke PN, Molloy A, et al. 1995. Folate levels and neural tube defects. Implications for prevention. JAMA 274:1698–1702.
14. Daly S, Mills JL, Molloy AM, et al. 1997. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 350:1666–1669.
15. De Wals P, Tairou F, Van Allen MI, et al. 2008. Spina bifida before and after folic acid fortification in Canada. Birth Defects Res A Clin Mol Teratol 82:622–626.
16. Elwood JH, Nevin NC. 1973. Anencephalus and spina bifida in Belfast (1964–1968). Ulster Med J 42:213–222.
17. GBD 2013 Mortality and Causes of Death Collaborators. 2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117–171.
18. Grosse SD, Waitzman NJ, Romano PS, Mulinare J. 2005. Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health. Am J Public Health 95:1917–1922.
19. Grosse SD, Berry RJ, Tilford JM, et al. 2016. Retrospective assessment of cost savings from prevention. Folic acid fortification and spina bifida in the U.S. Am J Prev Med 50:S74–S80.
20. Kancherla V, Druschel CM, Oakley GP Jr. 2014. Population-based study to determine mortality in spina bifida: New York State Congenital Malformations Registry, 1983 to 2006. Birth Defects Res A Clin Mol Teratol 100:563–575.
21. Huo Y, Li J, Qin X, et al. 2015. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 313:1325–1335.
22. Mosley BS, Cleves MA, Siega-Riz AM, et al. 2009. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 169:9–17.
23. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338:131–137.
24. Oakeshott P, Hunt GM, Poulton A, Reid F. 2010. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol 52:749–753.
25. Oakley GP Jr, Kancherla V. 2016. Will the Eastern Mediterranean Region be the first to prevent all of folic acid-preventable spina bifida and anencephaly? Saudi Med J 37:10–11.
26. Odewole OA, Williamson RS, Zakai NA, et al. 2013. Near-elimination of folate-deficiency anemia by mandatory folic acid fortification in older US adults: reasons for Geographic and Racial Differences in Stroke study 2003–2007. Am J Clin Nutr 98:1042–1047.
27. Ouyang L, Grosse SD, Armour BS, Waitzman NJ. 2007. Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res A Clin Mol Teratol 79:552–558.
28. Parfitt J, Barthel M, Macnaughton S. 2010. Food waste within food supply chains: quantification and potential for change to 2050. Philos Trans R Soc Lond B Biol Sci 365:3065–3081.
29. Sayed AR, Bourne D, Pattinson R, et al. 2008. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol 82:211–216.
30. Smith MA, Lau C. 2015. A resolution on folic acid fortification. Birth Defects Res A Clin Mol Teratol 103:1–2.
31. Stampfer M, Willett W. 2015. Folate supplements for stroke prevention: targeted trial trumps the rest. JAMA 313:1321–1322.
32. Sutton M, Daly LE, Kirke PN. 2008. Survival and disability in a cohort of neural tube defect births in Dublin, Ireland. Birth Defects Res A Clin Mol Teratol 82:701–709.
33. Wang Y, Hu J, Druschel CM, Kirby RS. 2011. Twenty-five-year survival of children with birth defects in New York State: a population-based study. Birth Defects Res A Clin Mol Teratol 91:995–1003.
34. Williams J, Mai CT, Mulinare J, et al. 2015. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995–2011. MMWR Morb Mortal Wkly Rep 64:1–5.
35. World Health Organization. 2015. Guideline: optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects. Geneva: World Health Organization.
36. Yang Q, Cogswell ME, Hamner HC, et al. 2010. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2006. Am J Clin Nutr 91:64–72.
37. Youngblood ME, Williamson R, Bell KN, et al. 2013. 2012 Update on global prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol 97:658–663.